http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2414049-A2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_34bd4e87ecbca17f16d460ca394e60f9 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D285-135 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 |
classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D285-12 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D285-135 |
filingDate | 1978-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 1979-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | FR-2414049-A2 |
titleOfInvention | NEW HETEROCYCLIC DERIVATIVES OF 7 H-1,3,4 - THIADIAZOLO - (3,2-A) PYRIMIDINE - 7 - ONE - 5 - CARBOXYLIC ACID, THEIR PROCESS OF PREPARATION AND THE MEDICINAL PRODUCT CONTAINING THEM |
abstract | THE ADDITION CONCERNS NEW DERIVATIVES WITH A BASIC SUBSTITUTE IN POSITION 2 OF 7H-1,3,4-THIADIAZOLO-3,2-APYRIMIDINE-7-ONE-5-CARBOXYL, THEIR ALKYL ESTERS AND OR THEIR ACCEPTABLE SALTS OF POINT FROM A PHARMACEUTICAL VIEW, ACCORDING TO THE MAIN PATENT. THESE DERIVATIVES ARE OBTAINED BY REACTION OF 2-AMINO-5- (BASIC SUBSTITUENT) -1,3,4-THIADIAZOLES WITH ACETYLENEDICARBOXYLIC ACID ESTERS AND POSSIBLE SUBSEQUENT SAPONIFICATION OF THE ESTER GROUP AND OR TRANSFORMATION IN ACCEPTABLE PHARMACEUTICAL SALTS OF POINT. DERIVATIVES OF THE ADDITION ARE NEW SUBSTANCES WHICH CAN BE USED AS ACTIVE SUBSTANCES IN MEDICINAL PRODUCTS; THEY ARE GIFT OF IMMUNO-STIMULATING ACTIVITY AND ARE SUITABLE, ESPECIALLY, FOR ANTI-INFECTIOUS TREATMENT. |
priorityDate | 1977-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 20.